Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Pharma & Drugs
Share your love
AI Detects Retinopathy of Prematurity with 100% Accuracy
In a study published in JAMA Ophthalmology, researchers from Oregon Health & Science University (OHSU) alongside international collaborators have unveiled an artificial intelligence (AI) technology capable of independently detecting all severe cases of a condition leading to blindness in prematurely…
MediPrint Finalizes Glaucoma Contact Lens Study
MediPrint Ophthalmics has successfully completed its SIGHT-2 phase 2b study, showcasing the efficacy of its innovative product, LL-BMT1, against a control group using bimatoprost 0.01% ophthalmic solution. LL-BMT1, a preservative-free, weekly drug-eluting contact lens, utilizes the company’s 3D printing technology,…
Sandoz Finalizes Acquisition of Cimerli from Coherus
Sandoz has successfully completed the acquisition of the United States biosimilar, Cimerli (ranibizumab-eqrn), from Coherus BioSciences. This strategic move underscores Sandoz’s commitment to expanding its portfolio in the biopharmaceutical sector, particularly in the area of biosimilars. The transaction, initially announced…
Amring Pharma Announces Name Change to Nordic Pharma
In a significant corporate rebranding, Amring Pharmaceuticals has officially adopted the name Nordic Pharma. This renaming marks a new chapter following the acquisition by Nordic Group, a subsidiary of Sever Life Sciences, on June 1, 2023. The strategic move aims…
Glaukos’ iDose TR Hits the Commercial Market
Glaukos Corporation’s iDose TR, using Celanese’s VitalDose EVA (Ethylene Vinyl Acetate), to provide sustained drug release for the treatment of glaucoma has officially entered the commercial market. Having received FDA approval in December, iDose TR represents a notable departure from…
Study Uncovers Eye’s Defense Against Brain Infections
In a study published in the journal Nature, researchers have found that vaccines injected into the eyes of mice can effectively combat the herpes virus, a leading cause of brain encephalitis. Contrary to expectations, the vaccine triggers an immune response…
FDA Recalls Some Eye Ointments Over Infection Risk
Eye ointment products manufactured in India and sold in the United States at major retailers like Walmart and CVS are being recalled due to a danger of infection. Brassica Pharma Pvt. Ltd., based in Maharashtra, India, announced the recall of…
CorNeat Vision Introduces CorNeat EverPatch in the U.S.
CorNeat Vision has launched the CorNeat EverPatch in the United States, a novel synthetic tissue-integrating matrix poised to transform ophthalmic surgeries. Endorsed by leading surgeons across the US, this FDA-cleared device marks a significant advancement in addressing complications associated with…
Amring Names Dr. Donnenfeld as U.S. Advisory Board Chair
Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V., announced the appointment of Dr. Eric D. Donnenfeld, a distinguished figure in ophthalmology, as the Chair of its U.S. Medical Advisory Board (MAB). This strategic decision comes as the company gears…
Dry Eye Disease in Postmenopausal Women
A common ocular problem is dry eye syndrome. Women are more likely to acquire dry eye syndrome and its accompanying detrimental implications on their general eye health, especially menopausal women with comorbidities. One of the most common ocular disorders is…